$ALLR Shreds past management...but does it delicately as a European should😂

$ALLR Eisai fully licensed Stenoparib to Allarity bec they were exiting the Oncology space and were selling off assets fiercebiotech.com/biotech/exclus…

$ALLR Thomas talks about his approach to financings vs old managing that was not beneficial to long term shareholders....again you can see how uncomfortable he is bashing them...he's too nice

$ALLR Now Stenoparib - Jeremy talks about what a unique PARPi it is...with dual mechanism of action

$ALLR Durable long term benefit...over 17 months now

$ALLR As opposed to all other PARPi effective even without BRCA mutation!!

$ALLR Incredible - Complete response happened within 7 weeks!!! wild stuff!

$ALLR 7 weeks CR is wild

My take on the $ALLR earnings: The only thing I was focused on was the Outstanding share count. I calculated 8.5m shares based on discussions with IR back in November. While I hoped the share count would stay the same, the company went ahead and tapped the remaining ATM

$ALLR my homeboy in for the ride

$ALLR In case you are wondering...yes its a short from .84 dont worry well bust u

$ALLR Don't short & come crying to me later. You are warned.

$ALLR Cash rich bios with robust pipelines are going to win within the next yr...look for M&A as well in this sector..this one wins imo bec of clean balance sheet etc but more than anything Stenoparib is rock solid

$ALLR

$ALLR “The stock market is a device for transferring money from the impatient to the patient.” -Warren Buffett We all know it, but do we practice??

$ALLR insider buying/institutional ownership soon to follow imo...keep your eyes peeled

$ALLR 🔥

$ALLR absolutely incredible what Stenoparib can do w BID...twice daily is night & day comp to once 600mg...will be interesting to see if even better w 400/400mg

$ALLR best value under-the-radar play in bio at the moment imo

$ALLR correct. Watch as many forgotten names start spiking..